Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Drug interactions with radiopharmaceuticals.
Hesslewood S, Leung E. Hesslewood S, et al. Eur J Nucl Med. 1994 Apr;21(4):348-56. doi: 10.1007/BF00947972. Eur J Nucl Med. 1994. PMID: 8005160 Review.
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.
Seymour LW, Ferry DR, Anderson D, Hesslewood S, Julyan PJ, Poyner R, Doran J, Young AM, Burtles S, Kerr DJ; Cancer Research Campaign Phase I/II Clinical Trials committee. Seymour LW, et al. Among authors: hesslewood s. J Clin Oncol. 2002 Mar 15;20(6):1668-76. doi: 10.1200/JCO.2002.20.6.1668. J Clin Oncol. 2002. PMID: 11896118 Clinical Trial.
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
Seymour LW, Ferry DR, Kerr DJ, Rea D, Whitlock M, Poyner R, Boivin C, Hesslewood S, Twelves C, Blackie R, Schatzlein A, Jodrell D, Bissett D, Calvert H, Lind M, Robbins A, Burtles S, Duncan R, Cassidy J. Seymour LW, et al. Among authors: hesslewood s. Int J Oncol. 2009 Jun;34(6):1629-36. doi: 10.3892/ijo_00000293. Int J Oncol. 2009. PMID: 19424581 Clinical Trial.
Radiopharmaceutical kit modification.
Lazarus C, Palmer AM, Hesslewood SR. Lazarus C, et al. Among authors: hesslewood sr. Nucl Med Commun. 1998 Jul;19(7):613-4. doi: 10.1097/00006231-199807000-00001. Nucl Med Commun. 1998. PMID: 9853340 No abstract available.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page